Investigation into potent inflammation inhibitors from traditional Chinese medicine. - Wikidata - awgldk - TriplyDB

Investigation into potent inflammation inhibitors from traditional Chinese medicine.

Investigation into potent inflammation inhibitors from traditional Chinese medicine.

http://www.wikidata.org/entity/Q47278490

about

In silico identification of potent pancreatic triacylglycerol lipase inhibitors from traditional Chinese medicine Lead discovery for Alzheimer's disease related target protein RbAp48 from traditional Chinese medicine.Investigation of silent information regulator 1 (Sirt1) agonists from Traditional Chinese Medicine.Susceptible gene of stasis-stagnation constitution from genome-wide association study related to cardiovascular disturbance and possible regulated traditional Chinese medicine.Potential Protein Phosphatase 2A Agents from Traditional Chinese Medicine against Cancer.Investigation of anti-infection mechanism of lactoferricin and splunc-1.Potential retinoid x receptor agonists for treating Alzheimer's disease from traditional chinese medicine.Lead Screening for HIV of C-C Chemokine Receptor Type 5 Receptor Inhibited by Traditional Chinese Medicine.Design of glucagon-like Peptide-1 receptor agonist for diabetes mellitus from traditional chinese medicine.In silico design of BACE1 inhibitor for Alzheimer's disease by traditional Chinese medicine.In Silico Investigation of Cytochrome P450 2C9 in relation to Aging Using Traditional Chinese Medicine.In silico design for adenosine monophosphate-activated protein kinase agonist from traditional chinese medicine for treatment of metabolic syndromes.Ligand-based and structure-based investigation for Alzheimer's disease from traditional chinese medicine.In Silico Insight into Potent of Anthocyanin Regulation of FKBP52 to Prevent Alzheimer's Disease.Finding inhibitors of mutant superoxide dismutase-1 for amyotrophic lateral sclerosis therapy from traditional chinese medicine.Computational design of apolipoprotein E4 inhibitors for Alzheimer's disease therapy from traditional Chinese medicine.In Silico Identification of Potent PPAR-γ Agonists from Traditional Chinese Medicine: A Bioactivity Prediction, Virtual Screening, and Molecular Dynamics Study.Lead Screening for Chronic Obstructive Pulmonary Disease of IKK2 Inhibited by Traditional Chinese Medicine Treatment of rheumatoid arthritis with traditional chinese medicine.Potential mitochondrial isocitrate dehydrogenase R140Q mutant inhibitor from traditional Chinese medicine against cancers Lead screening for CXCR4 of the human HIV infection receptor inhibited by traditional Chinese medicine Lead screening for HIV-1 integrase (IN) inhibited by traditional Chinese medicine.In silico investigation of potential mTOR inhibitors from traditional Chinese medicine for treatment of Leigh syndrome The inhibition of folylpolyglutamate synthetase (folC) in the prevention of drug resistance in Mycobacterium tuberculosis by traditional Chinese medicine Drug design of cyclin-dependent kinase 2 inhibitor for melanoma from traditional Chinese medicine.Treatment of cardiovascular disease by traditional Chinese medicine against pregnane X receptor In silico investigation of potential TRAF6 inhibitor from traditional Chinese medicine against cancers.In silico investigation of potential pyruvate kinase M2 regulators from traditional Chinese medicine against cancers.Potential smoothened inhibitor from traditional Chinese medicine against the disease of diabetes, obesity, and cancer Three-in-one agonists for PPAR-α, PPAR-γ, and PPAR-δ from traditional Chinese medicine.Investigation of the novel lead of melanocortin 1 receptor for pigmentary disorders.Cerebrospinal fluid pharmacology: an improved pharmacology approach for chinese herbal medicine research.Pharmacological chaperone design for reducing risk factor of Parkinson's disease from traditional chinese medicine.Han ethnicity-specific type 2 diabetic treatment from traditional Chinese medicine?A possible strategy against head and neck cancer: in silico investigation of three-in-one inhibitors.Broadleaf Mahonia attenuates granulomatous lobular mastitis‑associated inflammation by inhibiting CCL‑5 expression in macrophages.Traditional Chinese medicine as dual guardians against hypertension and cancer?Mechanism of BAG1 repair on Parkinson's disease-linked DJ1 mutation.

P2860

Q28483629-93A21F66-3004-41A7-B8CC-C82B88C33A33 Q30366183-FCECBB29-CB35-4144-8F0C-8C9D24E4DFDD Q30422493-70573A27-DA6A-404A-983C-C6ED84B3B559 Q30657668-CE3C5172-C2A7-4956-82E0-5C10241463BB Q33608964-AB44C897-0327-4D4E-A043-9FD0D672BD18 Q33614360-2BCE0611-ABE8-42EC-A8EC-A019F0AE95B7 Q33614602-4D3B2454-9619-413D-B245-D86DB27CE348 Q33615005-034FAE71-6CB9-481D-9FE7-747B3086BA38 Q33661003-AA129081-96F4-4C6D-A1CC-EAA1D3E52963 Q33666808-76D7329F-0B18-4932-8754-485F9FBED148 Q33668052-1E3D30E1-AB02-405D-A35A-A594160658D5 Q33668408-3BE26059-C934-45D4-B305-137B9DC88260 Q33668480-9C5516F0-CDFC-48E6-92BD-1919C2EE2A60 Q33678309-8A2DDA32-44C0-49C8-919E-DC19529BB0C6 Q33736326-16B7D047-C5D6-4B60-8CD9-6F1BF35CFC22 Q33747644-14FF77F6-60BE-45A5-9C67-C7CF2029F453 Q33757779-4E4EB67C-1EC6-4B15-B63B-814EBFC578EC Q33766033-26B72279-49EA-41FA-A589-61739576DE96 Q33786655-11A7CCDC-7441-4420-8E0A-B61C64CCDE27 Q33790946-CA7E2596-777F-4648-AA90-261FA93A1A88 Q33791008-8CEDBE04-89E3-407B-9970-3C3F0216D3A0 Q33810342-0CCA8352-95F8-4F29-B4D7-DFA6056BA050 Q33876312-EF6095A4-F8F9-46F5-B44B-363A0274E738 Q33876498-FC4BD8E8-D7AE-4066-8624-8B47D9576C2C Q33876519-0E3EED6E-31C7-4D97-9B14-F1699F604E12 Q33876600-F6C5CD59-92EC-465E-966B-5C31DA6AE23C Q33893880-069B7D5A-BF0D-4363-BD76-C46688A51DF8 Q33895166-A59381A9-A07F-4486-81CA-37E36524B46C Q34022289-E7B282DF-2B9F-429B-838B-A2C78829BE40 Q34316470-D8B1D00C-4BA3-46E5-B86B-F44F18270B99 Q35137889-2291A364-B6A9-410C-A420-74B028DE77BF Q37127221-1DBEB685-738B-4D30-B5C0-6A7ED3981DDA Q37556518-4E028D91-D97B-4E84-8C22-F8BC42E63D34 Q44806080-85497451-1EC2-4AC7-A7D5-E8DB8134517B Q44999449-4B3B971E-D631-4375-9066-F60C80048A09 Q46261261-D65BE72A-4772-4F47-BA73-9107358BFD08 Q47197241-567A91F1-18BB-4170-BD8B-0016EEFB9F46 Q52625121-0533DD5C-FB4F-4BDB-86E5-C21E05E6B6D9

P2860

Investigation into potent inflammation inhibitors from traditional Chinese medicine.

http://www.wikidata.org/entity/Q47278490

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Investigation into potent inflammation inhibitors from traditional Chinese medicine.

@en

Investigation into potent inflammation inhibitors from traditional Chinese medicine.

@nl

type

label

Investigation into potent inflammation inhibitors from traditional Chinese medicine.

@en

Investigation into potent inflammation inhibitors from traditional Chinese medicine.

@nl

prefLabel

Investigation into potent inflammation inhibitors from traditional Chinese medicine.

@en

Investigation into potent inflammation inhibitors from traditional Chinese medicine.

@nl

P1433

Q47278490-9771E24A-D9B5-43A6-8A45-952290A1A806

P1476

Q47278490-76FEDC49-7689-401D-A8B4-035C88BA6106

P2093

Q47278490-0752406B-B99F-48E7-8CD2-BF7417439A25

Q47278490-3D41DB34-6858-417D-A107-7A652D4B0A17

Q47278490-50F63814-2153-405C-B91F-8750D981F0AA

Q47278490-85A27A03-B294-4706-9001-60C8BDA9E268

Q47278490-9E197322-90D7-4A07-90A0-FDEAD5BA5C6D

Q47278490-D53F27AE-1D2C-4F6B-9620-1E339268220A

Q47278490-D6837F4B-9FB4-4429-8BC4-A02E3A931141

P2860

Q47278490-0D45EFD4-7A61-44D1-AA5B-17D5D810D38B

Q47278490-1B306D9E-FA3E-4A3B-87A8-329AC1FDED3C

Q47278490-1ED1840D-CB8B-4D7E-AC24-970661D427F7

Q47278490-260D7A33-634A-4444-9699-1CDD634E4A2F

Q47278490-2BAEBD92-9E61-420D-9442-D50D230B7B2C

Q47278490-2DB7A5EB-5069-49D4-A2BC-3080A871299F

Q47278490-390B8C8D-A650-4C90-B816-351A8C4F0657

Q47278490-39274A4C-1F1C-48E6-ADA1-E209298ABE56

Q47278490-458D03AA-31A4-4BBA-824F-CEE39AB051E2

Q47278490-585825A7-3352-4ACF-8BBC-7902655E81DC

P304

Q47278490-F56FA1A5-7BB0-40DE-AF32-5BA4E8BE2C0D

P31

Q47278490-D22BE2F4-38EC-48C5-9ED2-25F9D6FB246F

P356

Q47278490-4C7879D8-B0DF-4156-9C52-41B25E4E11BC

P433

Q47278490-4C18A1DB-30EF-4D3C-A3A5-6611BEE60DE2

P478

Q47278490-59697A54-83B8-42CE-B088-B6187797CEBD

P577

Q47278490-FB4B97EC-CA7F-4DCC-B9B5-706EDFF63593

P698

Q47278490-C1334F14-FEC5-497C-A985-6C17C7B74688

P921

Q47278490-A95288A3-1EB6-4383-A7E8-4EF82215431B

P356

J.1747-0285.2011.01202.X

P1433

Chemical Biology and Drug Design

P1476

Investigation into potent inflammation inhibitors from traditional Chinese medicine.

@en

P2093

Calvin Yu-Chian Chen

http://www.w3.org/2001/XMLSchema#string

Fuu-Jen Tsai

http://www.w3.org/2001/XMLSchema#string

Hsin-Yi Chen

http://www.w3.org/2001/XMLSchema#string

Kuan-Chung Chen

http://www.w3.org/2001/XMLSchema#string

Mao-Feng Sun

http://www.w3.org/2001/XMLSchema#string

Shun-Chieh Yang

http://www.w3.org/2001/XMLSchema#string

Su-Sen Chang

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability

Structural basis for induced formation of the inflammatory mediator prostaglandin E2.

Anti-inflammatory drugs in the 21st century

Molecular therapeutic target for type-2 diabetes

TCM Database@Taiwan: the world's largest traditional Chinese medicine database for drug screening in silico

Virtual screening and drug design for PDE-5 receptor from traditional Chinese medicine database.

Inhibitors of the microsomal prostaglandin E(2) synthase-1 as alternative to non steroidal anti-inflammatory drugs (NSAIDs)--a critical review.

Structural bioinformatics and its impact to biomedical science.

Progress in computational approach to drug development against SARS.

Recent advances in QSAR and their applications in predicting the activities of chemical molecules, peptides and proteins for drug design.

P304

679-688

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1747-0285.2011.01202.X

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

78

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21801310

http://www.w3.org/2001/XMLSchema#string

P921